Item 9 Labs's average Accounts Receivable for the
three
months ended in Jun. 2023 was $0.78 Mil. Item 9 Labs's Revenue for the
three
months ended in Jun. 2023 was $5.02 Mil.
Hence, Item 9 Labs's Days Sales Outstanding for the
three
months ended in Jun. 2023 was 14.21.
The historical rank and industry rank for Item 9 Labs's Days Sales Outstanding or its related term are showing as below:
INLB'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 6.46 Med: 18.27 Max: 344.72
Current: 12.4
During the past 13 years, Item 9 Labs's highest Days Sales Outstanding was 344.72. The lowest was 6.46. And the median was 18.27.
INLB's Days Sales Outstanding is ranked better than 95.5% of 1000
companies
in the Drug Manufacturers industry
Industry Median: 71.68
vs INLB: 12.40
Item 9 Labs's Days Sales Outstanding
declined
from Jun. 2022 (16.37) to Jun. 2023 (14.21).
Item 9 Labs Days Sales Outstanding Historical Data
The historical data trend for Item 9 Labs's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Item 9 Labs's Days Sales Outstanding
For the Drug Manufacturers - Specialty & Generic subindustry, Item 9 Labs's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Item 9 Labs's Days Sales Outstanding Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Item 9 Labs's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Item 9 Labs's Days Sales Outstanding falls into.
Item 9 Labs Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Item 9 Labs (OTCPK:INLB) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Item 9 Labs Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Item 9 Labs's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Item 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The company also offers a dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. It also brings industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INLB has been successfully added to your 